Search

Your search keyword '"Cahn, J.-Y."' showing total 569 results

Search Constraints

Start Over You searched for: Author "Cahn, J.-Y." Remove constraint Author: "Cahn, J.-Y."
569 results on '"Cahn, J.-Y."'

Search Results

1. Rapid response system for critically ill patients with haematological malignancies: A pre‐ and post‐intervention study.

3. Outcome in patients with diffuse large B-cell lymphoma who relapse after autologous stem cell transplantation and receive active therapy. A retrospective analysis of the Lymphoma Working Party of the European Society for Blood and Marrow Transplantation (EBMT)

4. Reduced intensity allogeneic stem cell transplantation for follicular lymphoma relapsing after an autologous transplant achieves durable long-term disease control: an analysis from the Lymphoma Working Party of the EBMT

5. Validation of the revised IPSS at transplant in patients with myelodysplastic syndrome/transformed acute myelogenous leukemia receiving allogeneic stem cell transplantation: a retrospective analysis of the EBMT chronic malignancies working party

7. Effect of immune modulation in relapsed peripheral T-cell lymphomas after post-allogeneic stem cell transplantation: a study by the Société Française de Greffe de Moelle et de Thérapie Cellulaire (SFGM-TC)

11. Conditioning intensity in middle-aged patients with AML in first CR: no advantage for myeloablative regimens irrespective of the risk group–an observational analysis by the Acute Leukemia Working Party of the EBMT

13. Prospective Comparison of Allogeneic Bone Marrow Transplantation, Intensive Consolidation Chemotherapy, and Unpurged Autologous Bone Marrow Transplantation as Post-Remission Therapy in Adult Acute Myeloid Leukemia

14. Granulocyte-Macrophage Colony-Stimulating Factor During and After Remission Induction Treatment for Elderly Patients with Acute Myeloid Leukemia

15. Mitoxantrone/Cytarabine with or without Quinine as a Potential MDR- Reversing Agent for the Treatment of Acute Leukemias

17. Ph+ ALL patients in first complete remission have similar survival after reduced intensity and myeloablative allogeneic transplantation: impact of tyrosine kinase inhibitor and minimal residual disease

19. The outcome of reduced intensity allogeneic stem cell transplantation and autologous stem cell transplantation when performed as a first transplant strategy in relapsed follicular lymphoma: an analysis from the Lymphoma Working Party of the EBMT

22. The impact of total body irradiation on the outcome of patients with follicular lymphoma treated with autologous stem-cell transplantation in the modern era: a retrospective study of the EBMT Lymphoma Working Party†

29. OUTCOMES OF CORD BLOOD TRANSPLANTATION USING REDUCED INTENSITY CONDITIONING REGIMEN FOR CHRONIC LYMPHOCITYC LEUKEMIA: A RETROSPECTIVE STUDY ON BEHALF OF EUROCORD, SFGM-TC AND CMWP-EBMT: PH-P087

30. CONDITIONING INTENSITY IN MIDDLE AGED PATIENTS WITH AML IN CR1. NO ADVANTAGE FOR MYELOABLATIVE REGIMENS IRRESPECTIVE OF THE RISK GROUP. AN OBSERVATIONAL ANALYSIS BY THE ACUTE LEUKEMIA WORKING PARTY OF THE EBMT: PH-O148

31. DOUBLE CORD BLOOD TRANSPLANTATION: INCIDENCE, ORGAN INVOLVEMENT AND RISK FACTORS OF ACUTE GRAFT VERSUS HOST DISEASE. A RETROSPECTIVE ANALYSIS ON BEHALF OF EUROCORD-EBMT: PH-O140

32. UNRELATED CORD BLOOD TRANSPLANTATION IN ADULTS WITH PRIMARY AND SECONDARY MYELOFIBROSIS: A RETROSPECTIVE STUDY ON BEHALF OF EUROCORD AND CMWP-EBMT: PH-O107

34. Long-term outcomes of adults with acute lymphoblastic leukemia after autologous or unrelated donor bone marrow transplantation: a comparative analysis by the National Marrow Donor Program and Center for International Blood and Marrow Transplant Research

37. Comparison of outcomes of HCT in blast phase of BCR-ABL1(-) MPN with de novo AML and with AML following MDS

38. Maintenance Tyrosine Kinase Inhibitors Following Allogeneic Hematopoietic Stem Cell Transplantation for Chronic Myelogenous Leukemia: A Center for International Blood and Marrow Transplant Research Study

39. Outcome in patients with diffuse large B-cell lymphoma who relapse after autologous stem cell transplantation and receive active therapy. A retrospective analysis of the Lymphoma Working Party of the European Society for Blood and Marrow Transplantation (EBMT).

44. A potential graft-versus-leukemia effect after allogeneic hematopoietic stem cell transplantation for patients with Philadelphia chromosome-positive acute lymphoblastic leukemia: results from the French Bone Marrow Transplantation Society

Catalog

Books, media, physical & digital resources